AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $7,134,000 | -40.1% | 371,174 | -8.0% | 1.07% | -39.5% |
Q2 2019 | $11,918,000 | -36.5% | 403,318 | +2.1% | 1.77% | -42.7% |
Q1 2019 | $18,763,000 | +94.6% | 395,020 | +47.9% | 3.08% | +78.9% |
Q4 2018 | $9,641,000 | -40.2% | 267,067 | +2.0% | 1.72% | -24.9% |
Q3 2018 | $16,120,000 | – | 261,893 | – | 2.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |